期刊文献+

人参皂苷CK诱导人肝癌HepG-2细胞凋亡的研究 被引量:8

Effect of ginsenoside CK on apoptosis of human hepatocellular carcinoma Hep G- 2 cells
原文传递
导出
摘要 目的探讨人参皂苷CK对人肝癌HepG-2细胞凋亡的作用及机制。方法采用MTT法测定不同浓度(30,60,90μmol/L)人参皂苷CK对人肝癌HepG-2细胞的增殖抑制作用;通过HE染色、AO/EB染色观察人参皂苷CK诱导人肝癌HepG-2细胞凋亡的形态学变化;WesternBlotting检测凋亡相关蛋白P53、Bax和Bcl-2的表达情况。结果人参皂苷CK可明显抑制人肝癌HepG-2细胞的增殖,且呈剂量依赖性和时间依赖性。随着人参皂苷CK给药浓度的增加,出现典型凋亡形态特征的细胞逐渐增多,抗凋亡蛋白Bcl-2和P53表达量逐渐下降,而促凋亡蛋白Bax的表达逐渐升高,Bcl-2/Bax比例明显降低。结论人参皂苷CK可诱导人肝癌HepG-2细胞凋亡,其作用机制可能与下调P53蛋白表达和降低Bcl-2/Bax比例有关。 Objective To investigate the effect of ginsenoside CK on apoptosis of human hepatocellular carcinoma Hep G- 2 cells and the mechanism. Methods human hepatocellular carcinoma Hep G- 2 cells were treated with different doses( 30,60,90μmol /L) of ginsenoside CK. Cell growth inhibitive rate was measured by MTT assay; Morphological changes of Hep G- 2 cells were observed by HE staining and AO / EB staining; The protein expression of P53,Bax and Bcl- 2 were analyzed by western blotting. Results Ginsenoside CK inhibited proliferation of Hep G- 2 cells in dosage- dependent manner and time- dependent manner. In comparison with control group,treated groups altered cell morphology and detected apoptosis of tumor cells,and the expression of P53 and Bcl- 2 were decreased obviously and Bax was elevated by western blotting. Conclusion Ginsenoside CK induce apoptosis of human hepatocellular carcinoma Hep G- 2 cells and the main mechanism are related to cut P53 protein and reduce Bcl- 2 / Bax ratio.
机构地区 延边大学医学院
出处 《时珍国医国药》 CAS CSCD 北大核心 2016年第4期843-845,共3页 Lishizhen Medicine and Materia Medica Research
关键词 人参皂苷CK HEPG-2细胞 细胞凋亡 内质网应激 Ginsenoside CK Hep G-2 cell Apoptosis Endoplasmic reticulum stress
  • 相关文献

参考文献4

  • 1Thomas M. Molecular targeted therapy for hepatocellular carcinoma [J]. J Gastro enterol, 2009, 19: 136.
  • 2郭明,伍周玲,王春歌,高小艳.黄芩苷-金属配合物的合成及其抗肿瘤活性研究[J].药学学报,2014,49(3):337-345. 被引量:25
  • 3Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010 [J]. J Nat Prod, 2012, 75(3) : 311.
  • 4Butler MS. Natural products to drugs: natural product derived compounds in clinical trials [J]. Nat Prod Rep, 2008, 25(3) : 475.

二级参考文献9

共引文献24

同被引文献68

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部